MicroRNA-155 in the Heart-Reference-Cited by-同舟云学术

MicroRNA-155 in the Heart

Published:2015-05-05 Issue:18 Volume:131 Page:1533-1535
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Rayner Katey J.¹

Affiliation:

1. From University of Ottawa Heart Institute, Ottawa, ON, Canada; and Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Epidemiology and risk profile of heart failure

2. Concise Review: Cell Therapy and Tissue Engineering for Cardiovascular Disease

3. MicroRNA-155 Exerts Cell-Specific Antiangiogenic but Proarteriogenic Effects During Adaptive Neovascularization

4. The Human Angiotensin II Type 1 Receptor +1166 A/C Polymorphism Attenuates MicroRNA-155 Binding

5. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha -induced cell death in fibroblasts

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current concepts in the epigenetic regulation of cardiac fibrosis;Cardiovascular Pathology;2024-11

2. Epigenetics of NAFLD and NASH;Epigenetics in Organ Specific Disorders;2023

3. An AC electrokinetics-based electrochemical aptasensor for the rapid detection of microRNA-155;Biosensors and Bioelectronics;2022-03

4. The effect of long-term left ventricular assist device support on flow-sensitive plasma microRNA levels;International Journal of Cardiology;2021-09

5. miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis;International Journal of Molecular Sciences;2018-12-10